Over 100 California Auctions End Today - Bid Now
Over 350 Total Lots Up For Auction at Two Locations - CO 05/12, PA 05/15

MD Anderson and Empyrean announce agreement to develop novel radiation therapy technologies

Press releases may be edited for formatting or style | August 10, 2022 Rad Oncology
Empyrean Medical Systems is an innovator and paradigm shifter in radiation oncology. The company aims to fundamentally change how cancer patients are treated worldwide while enhancing and improving every patient’s clinical outcome and quality of life. As a cutting-edge innovator, Empyrean aims to disrupt the fields of oncology and radiation oncology through the introduction of state-of-the-art medical devices, artificial intelligence analytical solutions, clinical applications and therapeutic agents. Empyrean’s multi-modal solutions provide personalized and effective health care, enhancing clinical productivity and improving outcomes for patients, providers, health systems and researchers worldwide.


About MD Anderson
The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution’s sole mission is to end cancer for patients and their families around the world. MD Anderson is one of only 53 comprehensive cancer centers designated by the National Cancer Institute (NCI). MD Anderson is No. 1 for cancer in U.S. News & World Report’s “Best Hospitals” rankings. It has been named one of the nation’s top two hospitals for cancer since the rankings began in 1990. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).
stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats


Back to HCB News

You Must Be Logged In To Post A Comment